RNDr. Pavel Krejčí, Ph.D.
Head of the research group, Pavel Krejčí Research Group
Office: bldg. C03/246
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5395 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 119
2015
-
A novel variant of FGFR3 causes proportionate short stature
European Journal od Endocrinology, year: 2015, volume: 172, edition: 6, DOI
-
Automated Cell Segmentation in Phase-Contrast Images based on Classification and Region Growing
Proceedings of 2015 IEEE International Symposium on Biomedical Imaging, 2015., year: 2015
-
Cross-talk of FGF and WNT signaling pathways during limb development.
Year: 2015, type: Conference abstract
-
Fate of the Molar Dental Lamina in the Monophyodont Mouse
Plos one, year: 2015, volume: 10, edition: 5, DOI
-
Fibroblast growth factor and canonical WNT/beta-catenin signaling cooperate in suppression of chondrocyte differentiation in experimental models of FGFR signaling in cartilage
Biochimica et Biophysica Acta - Molecular Basis of Disease, year: 2015, volume: 1852, edition: 5, DOI
-
HSP47 and FKBP65 cooperate in the synthesis of type I procollagen
Human Molecular Genetics, year: 2015, volume: 24, edition: 7, DOI
-
Instability restricts signaling of multiple fibroblast growth factors
Cellular and Molecular Life Sciences, year: 2015, volume: 72, edition: 12, DOI
-
Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method
Publisher: United States Patents and Trademark, state: United States, patent's number: US 9,057,106, year: 2015
-
Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3-Related Dwarfism
Journal of Pharmacology and Experimental Therapeutics, year: 2015, volume: 353, edition: 1, DOI
-
Nové terapeutické možnosti achondroplázie a založení registru pro malé lidi v ČR
Year: 2015, type: Conference abstract